1. Home
  2. AEIS vs GH Comparison

AEIS vs GH Comparison

Compare AEIS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advanced Energy Industries Inc.

AEIS

Advanced Energy Industries Inc.

HOLD

Current Price

$215.86

Market Cap

8.2B

Sector

Technology

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.02

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEIS
GH
Founded
1981
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
14.1B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
AEIS
GH
Price
$215.86
$101.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
21
Target Price
$210.22
$96.48
AVG Volume (30 Days)
327.1K
1.8M
Earning Date
02-11-2026
10-29-2025
Dividend Yield
0.18%
N/A
EPS Growth
236.95
N/A
EPS
3.81
N/A
Revenue
$1,724,842,000.00
$902,569,000.00
Revenue This Year
$22.40
$35.00
Revenue Next Year
$12.62
$26.80
P/E Ratio
$57.12
N/A
Revenue Growth
17.19
30.38
52 Week Low
$75.01
$29.91
52 Week High
$232.05
$112.43

Technical Indicators

Market Signals
Indicator
AEIS
GH
Relative Strength Index (RSI) 54.76 52.97
Support Level $213.00 $96.28
Resistance Level $218.85 $104.75
Average True Range (ATR) 7.15 3.42
MACD -0.45 -0.69
Stochastic Oscillator 63.58 51.64

Price Performance

Historical Comparison
AEIS
GH

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: